Florida medical cannabis sales surpass 5 billion milligrams of THC in 2026
Dispensaries reported over 1.7 million ounces of smokable marijuana sold through March, while organizers push for a new recreational ballot measure after the 2024 initiative failed.
Florida's medical marijuana market continues to grow. Through March 27, 2026, state-licensed dispensaries have dispensed more than 5.05 billion milligrams of THC and 1.71 million ounces of smokable marijuana to qualified patients, according to data from the Office of Medical Marijuana Use (OMMU).
By the numbers
The state's dispensary network has expanded to nearly 600 licensed locations, making Florida one of the most accessible medical marijuana markets in the country by sheer retail footprint. In addition to THC products, dispensaries reported dispensing 8,352 milligrams of CBD through the state's regulated program.
The numbers underscore Florida's position as one of the largest medical-only cannabis markets in the United States. The state's patient registry continues to grow, driven by a broad qualifying conditions list and an expanding network of recommending physicians.
The recreational question
These sales figures arrive against a backdrop of renewed political activity around adult-use legalization. Florida's 2024 recreational marijuana ballot measure — Amendment 3 — received 57% of the vote but failed to clear the state's 60% supermajority threshold required for constitutional amendments.
The result was notable: President Trump, a Florida resident, reportedly voted in favor of the measure. Despite that, the amendment fell roughly three percentage points short.
Organizers have regrouped and are now collecting signatures for a new recreational ballot initiative targeting the 2026 election cycle. The effort faces the same structural challenge — Florida's 60% threshold is among the highest in the nation for ballot measures — but proponents argue that higher turnout in a gubernatorial election year and refined messaging could close the gap.
Context
Florida's medical program, established after voters approved a constitutional amendment in 2016, has grown into a multi-billion-dollar market dominated by vertically integrated operators. Companies like Trulieve, Curaleaf, and Surterra operate dozens of locations each across the state.
The program's scale stands in contrast to Florida's conservative political environment. While the state's voters have consistently shown support for medical marijuana — the 2016 amendment passed with 71% of the vote — translating that support into full legalization has proven more difficult.
Whether a new ballot measure can succeed in 2026 will depend on turnout dynamics, campaign spending, and whether the political landscape shifts further in legalization's favor. For now, Florida remains a medical-only state with one of the largest patient populations and dispensary networks in the country.